Estrogen Replacement Therapy: Clinical Trials

4 trials of Estrogen Replacement Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Terminated 1
Phase 31Completed 1

Follow Estrogen Replacement Therapy: new trials by email Literature Review of Estrogen Replacement Therapy trials Research Report on Estrogen Replacement Therapy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
Sodium Cridanimod, progestin therapy - Endometrial Cancer
Phase 2TerminatedXenetic Biosciences, Inc.252017-06-142022-06-07
ELITE: Early Versus Late Intervention Trial With Estradiol
17B-estradiol, Placebo - Atherosclerosis
Phase 2CompletedUniversity of Southern California6432004-07-012023-01-18
Alzheimer's Disease: Therapeutic Potential of Estrogen
Transdermal estradiol, Medroxyprogesterone, Placebo Patch - Alzheimer Disease
Phase 2 / Phase 3CompletedUniversity of Wisconsin, Madison422001-09-012018-08-23
Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
Estrogen therapy - Atherosclerosis, Chlamydia Infections
Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)801999-05-012008-03-04

Conditions studied

Atherosclerosis (2)  ·  Alzheimer Disease (1)  ·  Cardiovascular Diseases (1)  ·  Chlamydia Infections (1)  ·  Coronary Artery Disease (1)  ·  Cytomegalovirus Infections (1)  ·  Endometrial Neoplasms (1)  ·  Pneumonia, Bacterial (1)  ·  Recurrence (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  University of Southern California (1)  ·  University of Wisconsin, Madison (1)  ·  Xenetic Biosciences, Inc. (1)

Countries

United States (4)

Top investigators

Curtis Lockshin, PhD (1)  ·  Howard N. Hodis, M.D. (1)  ·  Sanjay Asthana, MD (1)

Results publications

PMID 19996872, PMID 25405497, PMID 27028912, PMID 27421538, PMID 30272234, PMID 31362877, PMID 32925623, PMID 34736575, PMID 35526057, PMID 39980346

NIH funding

R01AG017196 (1), R01AG024154 (1)